Home LiteratureArticle Details
PMID: 21544958 Published · ppublish English Journal Article Review

Progress in the design and development of phosphoinositide 3-kinase (PI3K) inhibitors for the treatment of chronic diseases.

Progress in medicinal chemistry ·Vol. 48 ·2009-00-00 ·Pages 81-131

Shuttleworth S, Silva F, Tomassi C, Cecil A, Hill T, Rogers H, Townsend P

Abstract

暂无摘要

MeSH Terms
Animals Chronic Disease Drug Design Humans Neoplasms/drug therapy Phosphatidylinositol 3-Kinases/physiology Phosphoinositide-3 Kinase Inhibitors Protein Kinase Inhibitors/therapeutic use Signal Transduction
Chemicals
Phosphoinositide-3 Kinase Inhibitors Protein Kinase Inhibitors
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Shuttleworth Stephen
Karus Therapeutics Ltd., 2 Venture Road, Southampton Science Park, Southampton, S016 7NP, UK.
Silva Franck
Tomassi Cyrille
Cecil Alexander
Hill Thomas
Rogers Helen
Townsend Paul
Article Info
Journal
Progress in medicinal chemistry
Abbr.
Prog Med Chem
ISSN
0079-6468
DOI
10.1016/s0079-6468(09)04803-6
Published
2009-00-00
Pages
81-131
Language
English
Region
Netherlands
NLM ID
0376452
Subset
IM
External Links
PubMed source DOI: 10.1016/s0079-6468(09)04803-6
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2